Regulation and function of NF-κB transcription factors in the immune system
S Vallabhapurapu, M Karin - Annual review of immunology, 2009 - annualreviews.org
The mammalian Rel/NF-κB family of transcription factors, including RelA, c-Rel, RelB, NF-
κB1 (p50 and its precursor p105), and NF-κB2 (p52 and its precursor p100), plays a central …
κB1 (p50 and its precursor p105), and NF-κB2 (p52 and its precursor p100), plays a central …
NF-κB in cancer: from innocent bystander to major culprit
M Karin, Y Cao, FR Greten, ZW Li - Nature reviews cancer, 2002 - nature.com
Nuclear factor of κB (NF-κB) is a sequence-specific transcription factor that is known to be
involved in the inflammatory and innate immune responses. Although the importance of NF …
involved in the inflammatory and innate immune responses. Although the importance of NF …
Highly efficient expression of circular RNA aptamers in cells using autocatalytic transcripts
JL Litke, SR Jaffrey - Nature biotechnology, 2019 - nature.com
RNA aptamers and RNA aptamer-based devices can be genetically encoded and
expressed in cells to probe and manipulate cellular function. However, their usefulness in …
expressed in cells to probe and manipulate cellular function. However, their usefulness in …
NF-κB as a critical link between inflammation and cancer
M Karin - Cold Spring Harbor perspectives in biology, 2009 - cshperspectives.cshlp.org
NF-κB transcription factors have been suspected to be involved in cancer development
since their discovery because of their kinship with the v-Rel oncogene product. Subsequent …
since their discovery because of their kinship with the v-Rel oncogene product. Subsequent …
KSHV/HHV8-mediated hematologic diseases
E Cesarman, A Chadburn… - Blood, The Journal of …, 2022 - ashpublications.org
Kaposi sarcoma (KS) herpesvirus (KSHV), also known as human herpesvirus 8, is the
causal agent of KS but is also pathogenetically related to several lymphoproliferative …
causal agent of KS but is also pathogenetically related to several lymphoproliferative …
Lipoxins: nature's way to resolve inflammation
JA Chandrasekharan… - Journal of inflammation …, 2015 - Taylor & Francis
An effective host defense mechanism involves inflammation to eliminate pathogens from the
site of infection, followed by the resolution of inflammation and the restoration of tissue …
site of infection, followed by the resolution of inflammation and the restoration of tissue …
Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.
F Chang, LS Steelman, JT Lee… - Leukemia …, 2003 - search.ebscohost.com
Abstract The Ras/Raf/Mitogen-activated protein kinase/ERK kinase (MEK)/extracellular-
signal-regulated kinase (ERK) cascade couples signals from cell surface receptors to …
signal-regulated kinase (ERK) cascade couples signals from cell surface receptors to …
[HTML][HTML] NF-κB as a therapeutic target in multiple myeloma
T Hideshima, D Chauhan, P Richardson… - Journal of Biological …, 2002 - ASBMB
We have shown that thalidomide (Thal) and its immunomodulatory derivatives (IMiDs),
proteasome inhibitor PS-341, and As 2 O 3 act directly on multiple myeloma (MM) cells and …
proteasome inhibitor PS-341, and As 2 O 3 act directly on multiple myeloma (MM) cells and …
[HTML][HTML] Regulation of KSHV latency and lytic reactivation
G Broussard, B Damania - Viruses, 2020 - mdpi.com
Kaposi's sarcoma-associated herpesvirus (KSHV) is associated with three malignancies—
Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman's …
Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman's …
[HTML][HTML] Kaposi sarcoma–associated herpesvirus: immunobiology, oncogenesis, and therapy
DP Dittmer, B Damania - The Journal of clinical …, 2016 - Am Soc Clin Investig
Kaposi sarcoma–associated herpesvirus (KSHV), also known as human herpesvirus 8, is
the etiologic agent underlying Kaposi sarcoma, primary effusion lymphoma, and multicentric …
the etiologic agent underlying Kaposi sarcoma, primary effusion lymphoma, and multicentric …